Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: May 25, 2026
Back to directoryUnlearn medical AI product profile
Clinical-trial AI company using disease-specific machine learning models to generate participant-level digital twins for trial analysis.
Precision medicine and data
Best fit
Sponsors exploring smaller or more informative control arms, single-arm study context, interim looks, or trial power improvements with statistical review.
- Primary use case
- AI-generated digital twins for clinical trial design, control-outcome forecasting, synthetic control comparisons, and statistical power planning
- Audience
- Biopharma sponsors, CROs, clinical development leaders, biostatistics teams, and researchers designing clinical trials
- Risk level
- High
- Pricing signal
- Enterprise clinical trial and sponsor pricing; request current disease-model, study, and regulatory-support terms.
- Official sources
- 4 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
product-specific source-backed lens: These product-specific signals summarize what the cited sources imply before treating Unlearn as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as clinical trial methodology and evidence-generation infrastructure that needs protocol, SAP, ethics, sponsor, and regulator review before affecting enrollment or analysis. |
|---|---|
| Privacy | Review trial-participant data flows, baseline-variable scope, consent, de-identification, retention, transfers, automated-decision disclosures, and sponsor agreements. |
| Evidence | Inspect disease-model validation, calibration, external generalizability, uncertainty intervals, bias testing, and whether assumptions match the endpoint and population. |
| Workflow | Best used with biostatistical governance where digital-twin outputs are versioned, auditable, and reconciled with trial operations and regulatory commitments. |
Where Unlearn fits
Unlearn describes digital twins as AI-generated forecasts of individual trial participants' control outcomes using baseline data and historical clinical data; its privacy notice says AI is used to support clinical trial design and analysis rather than automated decisions about website visitors or customers.
Not for: Replacing randomized evidence, patient-level treatment decisions, or regulatory strategy without protocol-specific statistical, clinical, ethics, and agency review.
What to verify before using Unlearn
- Which disease-specific Digital Twin Generator and study design are in scope.
- Historical clinical data sources, baseline variables, validation, bias checks, uncertainty, and applicability to the trial population.
- How digital twins will be incorporated into the protocol, statistical analysis plan, regulatory engagement, and ethics review.
- Privacy, data-transfer, consent, de-identification, automated-decision, and customer-data handling terms for trial participant data.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- www.unlearn.ai / digital-twins
- www.unlearn.ai / privacy
- www.unlearn.ai / blog / how-unlearn-builds-trustworthy-ai-from-messy-clinical-data
- www.unlearn.ai / blog / our-strategy-for-navigating-the-regulatory-landscape-of-ai-in-drug-development
Related medical AI products
Precision medicine and data
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Tempus
AI-enabled precision medicine platform spanning molecular testing, multimodal data, clinical assistants, care pathways, imaging insights, and trial matching.
Precision medicine and data
SOPHiA GENETICS
AI-driven precision medicine platform for analyzing complex genomic, radiomic, and multimodal healthcare data.